12 Listings current as of Tuesday, Oct. 13, 2026. View the Mobile Meeting Guide App for more details. What We Don’t Do, What We Don’t See, What Comes Next: Device Therapy in Heart Failure 12:30–1:15 p.m. Heart Theater 2 SUPPORTER: Medtronic, Inc. A Novel Aldosterone-Targeted Treatment for Patients With Uncontrolled Hypertension 12:30–1:15 p.m. Learning Studio 1 SUPPORTER: AstraZeneca Unaddressed Risks: RAAS Dysregulation & the Role of Aldosterone in HF 12:30–1:15 p.m. Learning Studio 2 SUPPORTER: Boehringer Ingelheim Pharmaceuticals, Inc. CRISPR-Based Gene Editing: Expanding Horizons in Cardiac Care 12:30–1:15 p.m. Learning Studio 3 SUPPORTER: Intellia Therapeutics, Inc. Closing the Gap: Advancing Guideline-Directed Lipid Management and Treatment Intensification for High-Risk Patients 12:30–1:15 p.m. Learning Studio 4 SUPPORTER: Novartis Pharmaceutical Corporation Implementation in Action: Closing the Gap in ASCVD 12:30–1:15 p.m. Learning Studio 5 SUPPORTER: Amgen Inc. Obstructive HCM: Translating Evidence Into Practice 12:30–1:15 p.m. CardioTalk 2 SUPPORTER: Bristol Myers Squibb Advancing Lp(a) Care Through Shared Decision-Making 1:30–2 p.m. CardioTalk 2 SUPPORTER: (Heart) Implementation Science (QORA) Beyond Traditional HCM: Understanding Cardiac Disease Progression in Friedreich Ataxia 1:45–2:30 p.m. Heart Theater 1 SUPPORTER: Lexeo Therapeutics, Inc. Beyond Weight: Organ Crosstalk Throughout the Cardiometabolic Continuum 1:45–2:30 p.m. Learning Studio 3 SUPPORTER: Boehringer Ingelheim Pharmaceuticals, Inc. New Data on ATTR-CM for Healthcare Providers From CARDIO-TTRansform 1:45–2:30 p.m. Learning Studio 4 SUPPORTER: AstraZeneca Connecting at the Point of Care: Leveraging Industry Innovation With Integrated CKM Care Delivery 2–2:45 p.m. Industry Room N427D SPONSOR: (Heart) CardiovascularKidney-Metabolic Syndrome Seeing Women With Aortic Stenosis More Clearly: What SMART Reveals at 3 Years 3–3:30 p.m. CardioTalk 2 SUPPORTER: Medtronic, Inc. Diagnosing, Staging and Treating CAD - The TRANSFORM Trial 3:15–4 p.m. Learning Studio 3 SUPPORTER: Cleerly, Inc The Heart of CV Inflammation: Evidence and Evolving Science 3:15–4 p.m. Learning Studio 4 SUPPORTER: Novo Nordisk, Inc. Detecting ATTR-CM Before Heart Failure: The Next Frontier in Precision Cardiomyopathy 3:15–4:30 p.m. Industry Room N427D SUPPORTER: Pfizer Inc. 2026 INDUSTRY EVENTS Saturday, Nov. 7
RkJQdWJsaXNoZXIy MjI2NjI=